Bertrand Godeau

Active 1992–2025

132
Papers
21,769
Citations
83
h-index
124
i10-index

Citations

Citations per year for Bertrand Godeau1988: 3 citations1994: 1 citations1995: 6 citations1996: 5 citations1997: 7 citations1998: 5 citations1999: 12 citations2000: 13 citations2001: 11 citations2002: 17 citations2003: 26 citations2004: 13 citations2005: 31 citations2006: 17 citations2007: 27 citations2008: 41 citations2009: 57 citations2010: 68 citations2011: 108 citations2012: 100 citations2013: 106 citations2014: 138 citations2015: 156 citations2016: 128 citations2017: 163 citations2018: 128 citations2019: 601 citations2020: 854 citations2021: 876 citations2022: 535 citations2023: 421 citations2024: 651 citations2025: 232 citations2026: 4 citations1989–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,260 citing papers, 20.4% of this breakdownFrance: 557 citing papers, 9% of this breakdownUnited Kingdom: 487 citing papers, 7.9% of this breakdownChina: 443 citing papers, 7.2% of this breakdownItaly: 441 citing papers, 7.2% of this breakdownCanada: 265 citing papers, 4.3% of this breakdownGermany: 251 citing papers, 4.1% of this breakdownSpain: 206 citing papers, 3.3% of this breakdownJapan: 184 citing papers, 3% of this breakdownNetherlands: 164 citing papers, 2.7% of this breakdownAustralia: 158 citing papers, 2.6% of this breakdownSwitzerland: 138 citing papers, 2.2% of this breakdown
0%20.4%Other 26.1%

Fields

  • Medicine89.1%
  • Immunology and Microbiology7.2%
  • Biochemistry, Genetics and Molecular Biology2.2%
  • Social Sciences0.3%
  • Computer Science0.3%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • Other0.7%

Topics

  • Platelet Disorders and Treatments10.3%
  • Blood groups and transfusion8.1%
  • Systemic Lupus Erythematosus Research3.9%
  • COVID-19 Clinical Research Studies3.7%
  • SARS-CoV-2 and COVID-19 Research3.3%
  • Vasculitis and related conditions3%
  • Other67.7%

Coauthors

All papers

Open in search
  1. Updated international consensus report on the investigation and management of primary immune thrombocytopenia

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2019 cited by 1,090

  2. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

    Authors: , , , , , , , , , , , , , , , , , , , - Blood 2008 cited by 2,660

  3. International consensus report on the investigation and management of primary immune thrombocytopenia

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2009 cited by 2,267

  4. Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatism 2012 cited by 915

  5. Thrombopoietin receptor agonists: ten years later

    Authors: , , , , - Haematologica 2019 cited by 390

  6. Pathogenesis of immune thrombocytopenia

    Authors: , , , , - Autoimmunity Reviews 2017 cited by 365

  7. Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?

    Authors: , , , , , , , , , - European Journal of Cancer 2019 cited by 173

  8. Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anne-Laure Voisin, Bertrand Godeau, Christophe Massard, Vincent Ribrag, Aurélien Marabelle, Marc Michel, Olivier Lambotte - The Lancet Haematology 2018 cited by 292

  9. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France

    Authors: , , , , , - Blood 2014 cited by 342

  10. mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2021 cited by 142

  11. Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aurora Pujol, Marie Zins, Pierre Tiberghien, Paul Gray, Peter McNaughton, Anna Sullivan, Jane Peake, Romain Lévy, Laetitia Languille, Carlos Rodríguez‐Gallego, Bertrand Boisson, Sébastien Gallien, Bénédicte Neven, Marc Michel, Bertrand Godeau, Laurent Abel, F.A. Rey, Jean–Claude Weill, Claude–Agnès Reynaud, Stuart G. Tangye, Jean‐Laurent Casanova, Matthieu Mahévas - The Journal of Experimental Medicine 2022 cited by 47

  12. B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2012 cited by 194

  13. Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sonia Rizzello, Pascal Cohen, Giacomo Emmi, Benjamin Terrier - Annals of the Rheumatic Diseases 2023 cited by 53

  14. Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia

    Authors: , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 87

  15. Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia

    Authors: , , , , , , , , , - Haematologica 2021 cited by 50

  16. Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sabine Berthier, Emilie Berthoux, Holy Bezanahary, Lisa Biale, Boris Bienvenu, Claire Blanchard-Delaunay, Anne Calas, Pascal Cathebras, Claire Cazalets, Benjamin Chaigne, Olivia Chandesris, Jérémy Chatelais, Emmanuel Chatelus, Elodie Chauvet, Fleur Cohen, Pascal Coquerelle, Marion Couderc, Mathilde de Menthon, Claire de Moreuil, Juliette Delforge, Azeddine Dellal, Catherine Deneux-Tharaux, Amélie Denis, Emmanuelle Dernis, Alban Deroux, Sandra Desouches, Guillaume Direz, Maxime Dougados, Marine Driessen, Aurélie Du Thanh, Laetitia Dunogeant, Cécile Durant, Isabelle Durieu, Elisabeth Elefant, Marc Fabre, Olivier Fain, Nicole Ferreira-Maldent, René-Marc Flipo, Aline Frazier, Antoine Froissart, Sophie Georgin-Lavialle, Elisabeth Gervais, Bertrand Godeau, François Goffinet, Anne Gompel, Laure Gossec, Phillipe Goupille, Claire Grange, Constance Guillaud-Danis, Eric Hachulla, Aurélie Hummel, Moez Jallouli, Patrick Jego, Stéphane Jobard, Laurence Josselin-Mahr, Noémie Jourde-Chiche, Anne-Sophie Korganow, Marc Lambert, Vincent Langlois, Delphine Lariviere, Claire Larroche, Céline Lartigau-Roussin, Augustin Latourte, Christian Lavigne, Thomas Le Gallou, Gaëlle Leroux, Hervé Levesque, Frédéric Lioté, Laurence Loeuillet, Jonathan London and 48 more - Lara D. Veeken 2022 cited by 48

  17. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

    Authors: , , , , , , , , , , , , , , , , , - Blood 2012 cited by 344

  18. Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xavier Mariette, Jacques‐Eric Gottenberg - Arthritis & Rheumatism 2010 cited by 410

  19. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

    Authors: , , , , , , , , , , , , , , , , , , , - Blood 2013 cited by 248

  20. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L. Astudillo, C. Bélizna, Nadia Belmatoug, Olivier Benvéniste, A. Benyamine, Holly Bezanahary, Patrick Blanco, O Blétry, Bahram Bodaghi, Pierre Bourgeois, B. Brihaye, Emmanuel Chatelus, R. Damade, Éric Daugas, C. Degennes, Jean‐François Delfraissy, C. Delluc, Aurélien Delluc, P. Duhaut, Alain Dupuy, I. Durieu, E A Hang-Korng, Dominique Farge, Christian Funck‐Brentano, Frédérique Gandjbakhch, Justine Gellen‐Dautremer, Pascale Ghillani‐Dalbin, Bertrand Godeau, Cécile Goujard, C. Grandpeix, C. Grangé, Lamiae Grimaldi‐Bensouda, G. Guettrot-Imbert, Loïc Guillevin, É. Hachulla, Jean-Robert Harlé, Julien Haroche, Pierre Hausfater, Jean Jouquan, Gilles Kaplanski, Homa Keshtmand, Mehdi Khellaf, O. Lambotte, David Launay, H. Lévesque, Olivier Lidove, Eric Liozon, L Y Kim, Matthieu Mahévas, K. Mariampillai, Xavier Mariette, Alexis Mathian, K. Mazodier, Marc Michel, Nathalie Morel, Luc Mouthon, Rokiya Ngack, J. Ninet, Éric Oksenhendler, Jean‐Luc Pellegrin, Olivier Peyr, Anne‐Marie Piette, Vincent Poindron, Fabienne Roux, David Saadoun, Sabrinel Sahali, B. Saint-Marcoux, F. Sarrot-Reynauld, Y. Schoindre, Jérémie Sellam and 13 more - Annals of the Rheumatic Diseases 2012 cited by 206

  21. SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthieu Mahévas, Pascal Chappert - Immunity 2023 cited by 32

  22. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M Gaspard, C. Gaudin, Aurélie Godel-Labouret, P Giraud, S. Hadj‐Khelifa, Benjamin Hébraud, Sarah Khatibi, Lorraine Leplay, Y. Leveneur, Nicolas Limal, S. Ollier, S. Madaule, B. Marchou, C. Martel, Guillaume Martin‐Blondel, Philippe Montané de la Roque, Martin Michaud, J. Moeglin, F. Nuccio, L. Prudhomme, G. Pugnet, Christian Récher, Véronique Rémy, L. Sailler, Stéphane Sire, Agnès Sommet, Suzanne Tavitian, M.F. Thiercelin-Legrand, W. Vaillant - Journal of Thrombosis and Haemostasis 2018 cited by 136

  23. Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xavier Puéchal, Jean‐Emmanuel Kahn, Jens Thiel, Lorenzo Dagna, Loı̈c Guillevin, Augusto Vaglio, Giacomo Emmi, Benjamin Terrier, for the French Vasculitis Study Group and the European EGPA Study Group - Arthritis & Rheumatology 2020 cited by 94

  24. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study

    Authors: , , , , , , - British Journal of Haematology 2015 cited by 174